Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

Vor Biopharma Inc.

NASDAQ: VOR · Life Sciences · 2 alerts · CIK 1817229

Share price
$18.97Close, Nov 16
Market cap
$1.17B
Shares outstanding
61.43MLatest SEC cover page
Sector
Life Sciences
Industry
Biological Products, (No Diagnostic Substances)SIC 2836

Today's reference numbers: shares from the company's latest SEC cover page, price from the latest market close. Not a valuation or a recommendation. All Vor Biopharma Inc. filings on SEC EDGAR ↗

7:31 AM ET 8-K
Licensing Deal

Vor Biopharma Licensing Deal with RemeGen Co., Ltd. Worth $10M

Vor Biopharma expanded its existing partnership with RemeGen by entering into an amended and restated license agreement to add RC298, a next-generation dual BAFF/APRIL inhibitor, to its exclusive development and commercialization rights outside of Greater China. Vor Bio will pay an upfront cash payment of $10 million and issue a pre-funded warrant for 2.3 million shares, with RemeGen eligible for up to $630 million in development and regulatory milestones plus tiered royalties.

Value
$10M
Counterparty
RemeGen Co., Ltd.

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.